# Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

> **NCT04489459** · PHASE4 · UNKNOWN · sponsor: **Al-Azhar University** · enrollment: 60 (estimated)

## Conditions studied

- Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae

## Interventions

- **DRUG:** Colistin
- **DRUG:** Meropenem
- **DRUG:** Tigecycline

## Key facts

- **NCT ID:** NCT04489459
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-21
- **Primary completion:** 2020-07
- **Final completion:** 2020-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04489459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04489459, "Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04489459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*